An early Phase II study of intratumoral P-32 chromic phosphate injection therapy for patients with refractory solid tumors and solitary metastases
Open Access
- 15 February 1999
- Vol. 85 (4) , 980-987
- https://doi.org/10.1002/(sici)1097-0142(19990215)85:4<980::aid-cncr28>3.0.co;2-h
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- 9. Unsealed source radiation therapy for solid tumoursNuclear Medicine Communications, 1996
- Intralesional ethanol in the treatment of unresectable liver cancerWorld Journal of Surgery, 1995
- Phase Ib Trial of the Effect of Peritumoral and Intranodal Injections of Interleukin-2 in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck: An Eastern Cooperative Oncology Group TrialJournal of Immunotherapy, 1994
- Recombinant Human Tumor Necrosis Factor Causes Regression in Patients with Advanced MalignanciesOncology, 1994
- Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitroCarcinogenesis: Integrative Cancer Research, 1992
- Combined treatment of radiation and cisdiamminedichloroplatinum (II): a review of experimental and clinical dataInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Iodine-125 implants for carcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Antitumoral Activity of Human Fibroblast Interferon Administered IntranodularlyOncology, 1985
- Response of multicellular tumor spheroids to mutliple fractions of negative pi mesons and X raysInternational Journal of Radiation Oncology*Biology*Physics, 1981
- Studies in Stereoencephalotomy IIIStereotactic and Functional Neurosurgery, 1954